Bevacizumab antiangiogenic therapy for glioblastoma

被引：12
|
作者：
Junck, Larry [1 ]
机构：
[1] Univ Michigan Hlth Syst, Dept Neurol, Ann Arbor, MI 48109 USA
来源：
NEUROLOGY | 2011年 / 76卷 / 05期
关键词：
ANGIOGENESIS; PROGRESSION; INVASION; TUMORS; CELLS;
D O I：
10.1212/WNL.0b013e31820a0d7e
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：414 / 415
页数：2
相关论文
共 50 条
  • [31] Recurrent spinal cord glioblastoma: salvage therapy with bevacizumab
    Marc C. Chamberlain
    Sandra K. Johnston
    [J]. Journal of Neuro-Oncology, 2011, 102 : 427 - 432
  • [32] Recurrent spinal cord glioblastoma: salvage therapy with bevacizumab
    Chamberlain, Marc C.
    Johnston, Sandra K.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2011, 102 (03) : 427 - 432
  • [33] Rechallenge with bevacizumab in patients with glioblastoma progressing off therapy
    Bronnimann, Charlotte
    Izquierdo, Cristina
    Cartalat, Stephanie
    Thomas, Laure
    Joubert, Bastien
    Delpech, Laura
    Barritault, Marc
    Meyronet, David
    Honnorat, Jerome
    Ducray, Francois
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2018, 138 (01) : 141 - 145
  • [34] PRIMARY SPINAL CORD GLIOBLASTOMA: RESPONSE TO THERAPY WITH BEVACIZUMAB
    Walbert, Tobias
    Puduvalli, Vinay
    [J]. NEURO-ONCOLOGY, 2010, 12 : 44 - 44
  • [35] Rechallenge with bevacizumab in patients with glioblastoma progressing off therapy
    Charlotte Bronnimann
    Cristina Izquierdo
    Stéphanie Cartalat
    Laure Thomas
    Bastien Joubert
    Laura Delpech
    Marc Barritault
    David Meyronet
    Jérôme Honnorat
    François Ducray
    [J]. Journal of Neuro-Oncology, 2018, 138 : 141 - 145
  • [36] Zielgerichtete Antiangiogenese mit Bevacizumab und vaskuläre EreignisseVascular complications under antiangiogenic therapy with bevacizumab
    A. Loew
    H. Riess
    [J]. Der Onkologe, 2013, 19 (11): : 983 - 992
  • [37] INTRACELLULAR PH MEASURED BY 31P MR-SPECTROSCOPY PREDICTS SITE OF PROGRESSION IN RECURRENT GLIOBLASTOMA UNDER ANTIANGIOGENIC THERAPY WITH BEVACIZUMAB
    Wenger-Alakmeh, K. J.
    Pilatus, U.
    Hattingen, E.
    Baehr, O. R.
    [J]. NEURO-ONCOLOGY, 2016, 18 : 34 - 34
  • [38] Bevacizumab for glioblastoma
    Narita, Yoshitaka
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1759 - 1765
  • [39] Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma
    Nowosielski, Martha
    Wiestler, Benedikt
    Goebel, Georg
    Hutterer, Markus
    Schlemmer, Heinz P.
    Stockhammer, Guenther
    Wick, Wolfgang
    Bendszus, Martin
    Radbruch, Alexander
    [J]. NEUROLOGY, 2014, 82 (19) : 1684 - 1692
  • [40] Antiangiogenic gene therapy with VB111 is active in glioblastoma xenografts
    Brenner, Andrew J.
    Rogge, Jessica
    Cohen, Yael
    Breitbart, Eyal
    Livnat, Bangio
    [J]. CANCER RESEARCH, 2011, 71
12345